Economy
Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
Publication and source
PublicationSanalda Haber
SourceCNBC
Published
CategoryEconomy
Summary from the source publisher’s news feed.